When patients report cognitive symptoms, they are typically linked to metabolic adjustment, dehydration, or electrolyte imbalance during the first one to two weeks of treatment
10.1378/chest.12-2664 [DOI] [PubMed] [Google Scholar] 80.Zinellu E, Zinellu A, Pau MC, Piras B, Fois AG, Mellino S, et al
This perspective is being reshaped by emerging research that highlights the contribution of metabolic pathways to OA development and progression
GLP-1 medication changes may support long-term weight management Patients who switch obesity drugs after less than a year stay better engaged with their treatment, UTSW researchers find DALLAS March 10, 2026 Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didnt switch, according to a new study by UT Southwestern Medical Center researchers